BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34716533)

  • 1. Accelerated Maturation, Exhaustion, and Senescence of T cells in 22q11.2 Deletion Syndrome.
    Smetanova J; Milota T; Rataj M; Bloomfield M; Sediva A; Klocperk A
    J Clin Immunol; 2022 Feb; 42(2):274-285. PubMed ID: 34716533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?
    Vergaelen E; Schiweck C; Van Steeland K; Counotte J; Veling W; Swillen A; Drexhage H; Claes S
    Brain Behav Immun; 2018 May; 70():88-95. PubMed ID: 29567371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome.
    Dar N; Gothelf D; Korn D; Frisch A; Weizman A; Michaelovsky E; Carmel M; Yeshayahu Y; Dubnov-Raz G; Pessach IM; Simon AJ; Lev A; Somech R
    Pediatr Res; 2015 Apr; 77(4):579-85. PubMed ID: 25580739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study.
    Deshpande DR; Demirdag YY; Marsh RA; Sullivan KE; Orange JS;
    J Clin Immunol; 2021 Jan; 41(1):29-37. PubMed ID: 32949294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency.
    Barry JC; Crowley TB; Jyonouchi S; Heimall J; Zackai EH; Sullivan KE; McDonald-McGinn DM
    J Clin Immunol; 2017 Jul; 37(5):476-485. PubMed ID: 28540525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D status and the immune assessment in 22q11.2 deletion syndrome.
    Legitimo A; Bertini V; Costagliola G; Baroncelli GI; Morganti R; Valetto A; Consolini R
    Clin Exp Immunol; 2020 Jun; 200(3):272-286. PubMed ID: 32149392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Immunological Defects and Outcomes in Patients with Chromosome 22q11.2 Deletion Syndrome.
    Yu HH; Chien YH; Lu MY; Hu YC; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
    J Clin Immunol; 2022 Nov; 42(8):1721-1729. PubMed ID: 35925483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome.
    Montin D; Marolda A; Licciardi F; Robasto F; Di Cesare S; Ricotti E; Ferro F; Scaioli G; Giancotta C; Amodio D; Conti F; Giardino G; Leonardi L; Ricci S; Volpi S; Baselli LA; Azzari C; Bossi G; Consolini R; Dellepiane RM; Duse M; Gattorno M; Martire B; Putti MC; Soresina A; Plebani A; Ramenghi U; Martino S; Pignata C; Cancrini C
    J Allergy Clin Immunol Pract; 2019; 7(7):2369-2376. PubMed ID: 30922987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1/interferon-γ bias in 22q11.2 deletion syndrome is driven by memory T cells and exacerbated by IL-7.
    Vladyka O; Vrabcova P; Reiterova M; Parackova Z; Haesler R; Sediva A; Kalina T; Klocperk A
    Clin Immunol; 2023 Nov; 256():109793. PubMed ID: 37776967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of thymocyte commitment to regulatory T cell lineage in thymus of healthy subjects and patients with 22q11.2 deletion syndrome.
    Borna S; Dejene B; Lakshmanan U; Schulze J; Weinberg K; Bacchetta R
    Front Immunol; 2023; 14():1088059. PubMed ID: 37006241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome.
    Ferrando-Martínez S; Lorente R; Gurbindo D; De José MI; Leal M; Muñoz-Fernández MA; Correa-Rocha R
    J Pediatr; 2014 Apr; 164(4):882-9. PubMed ID: 24461789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome.
    Piliero LM; Sanford AN; McDonald-McGinn DM; Zackai EH; Sullivan KE
    Blood; 2004 Feb; 103(3):1020-5. PubMed ID: 14525774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 22q11.2 Deletion (DiGeorge Syndrome): Immunologic Features, Diagnosis, and Management.
    Biggs SE; Gilchrist B; May KR
    Curr Allergy Asthma Rep; 2023 Apr; 23(4):213-222. PubMed ID: 36897497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Lymphocytes in Patients With Nijmegen Breakage Syndrome Demonstrate Features of Exhaustion and Senescence in Flow Cytometric Evaluation of Maturation Pathway.
    Piatosa B; Wolska-Kuśnierz B; Tkaczyk K; Heropolitanska-Pliszka E; Grycuk U; Wakulinska A; Gregorek H
    Front Immunol; 2020; 11():1319. PubMed ID: 32695108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.
    Eberle P; Berger C; Junge S; Dougoud S; Büchel EV; Riegel M; Schinzel A; Seger R; Güngör T
    Clin Exp Immunol; 2009 Feb; 155(2):189-98. PubMed ID: 19040613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Autoimmune Thyroid Disease in a Cohort of 73 Paediatric Patients Affected by 22q11.2 Deletion Syndrome: Longitudinal Single-Centre Study.
    Ricci S; Sarli WM; Lodi L; Canessa C; Lippi F; Azzari C; Stagi S
    Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles.
    Lima K; Abrahamsen TG; Foelling I; Natvig S; Ryder LP; Olaussen RW
    Clin Exp Immunol; 2010 Jul; 161(1):98-107. PubMed ID: 20491792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular screening for 22Q11.2 deletion syndrome in patients with congenital heart disease.
    Huber J; Peres VC; de Castro AL; dos Santos TJ; da Fontoura Beltrão L; de Baumont AC; Cossio SL; Dalberto TP; Riegel M; Cañedo AD; Schaan BD; Pellanda LC
    Pediatr Cardiol; 2014 Dec; 35(8):1356-62. PubMed ID: 24880467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features.
    Gul KA; Øverland T; Osnes L; Baumbusch LO; Pettersen RD; Lima K; Abrahamsen TG
    J Clin Immunol; 2015 May; 35(4):408-15. PubMed ID: 25814142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.
    Crowley B; Ruffner M; McDonald McGinn DM; Sullivan KE
    Am J Med Genet A; 2018 Oct; 176(10):2082-2086. PubMed ID: 29341423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.